Phase II study of pemetrexed and carboplatin plus bevacizumab as first-line therapy in malignant pleural mesotheliomaCERESOLI, G. L; ZUCALI, P. A; SOTO-PARRA, H et al.British journal of cancer. 2013, Vol 109, Num 3, pp 552-558, issn 0007-0920, 7 p.Article

Prospective study of high-dose chemotherapy and autologous peripheral stem cell transplantation in adult patients with advanced desmoplastic small round-cell tumourBERTUZZI, A; CASTAGNA, L; SARINA, B et al.British journal of cancer. 2003, Vol 89, Num 7, pp 1159-1161, issn 0007-0920, 3 p.Article

Ifosfamide and vinorelbine : an active regimen for patients with relapsed or refractory Hodgkin's diseaseBONFANTE, V; VIVIANI, S; SANTORO, A et al.British journal of haematology. 1998, Vol 103, Num 2, pp 533-535, issn 0007-1048Article

Three-week versus four-week schedule of cisplatin and gemcitabine: results of a randomized phase II studySOTO PARRA, H; CAVINA, R; LATTERI, F et al.Annals of oncology. 2002, Vol 13, Num 7, pp 1080-1086, issn 0923-7534Article

Activity of a specific inhibitor, gefitinib (Iressa, ZD1839), of epidermal growth factor receptor in refractory non-small-cell lung cancerSANTORO, A; CAVINA, R; ALLOISIO, M et al.Annals of oncology. 2004, Vol 15, Num 1, pp 33-37, issn 0923-7534, 5 p.Article